European priority

The arrival of increasingly tailor-made new treatments and devices, robotics and ICT technologies represent a veritable tsunami for health care systems. They profoundly transform the traditional prevention methods and ways of diagnosing and treating a patient, changing the actual concept of health itself. Trying out innovative models for programming, organizing and managing services and performances and activating new forms of public/private collaboration, even outside of the health care system, become the two cornerstones upon which the next decade’s National Health Service will be based.
An NHS where prevention and innovation generate value, according to the equation Prevention + Innovation = Value, for the citizen and the system.


In recent years, the healthcare systems of advanced economies have undergone profound changes due primarily to two drivers: the evolution in social-demographic and epidemiological scenarios and the acceleration in scientific and technological innovation.

Recently, with Europe’s Health for Growth programs, investing in innovation, prevention and finding new models of sustainability have appeared on the agendas of the governments of member states.

Also, as a result of the economic-financial crisis, the last ten years in Italy have seen increased pressure placed upon public spending, with important interventions to contain expenditure on public health care. The current economic recovery, albeit moderate, makes it possible to set Italy’s National Health System on a new path towards reforming the overall system of governance that will include health in all policies, with a constant search for operating efficiency and value-based quality and effectiveness.

How can the health of the population be improved with a holistic approach that goes beyond the traditional healthcare boundaries?

How can the organizational models and financing methods for healthcare be rethought?

The European House – Ambrosetti is active in the healthcare and pharmaceutical sector in two main areas::

  • Policy research, strategic studies and working papers
  • Advocacy, public affairs and communication.

Policy research, strategic studies and working papers

We provide policy research on key areas of the national healthcare system, including international benchmarking activity and support for sector operators and players with the goal of developing and interpreting the changes in healthcare scenarios and bolstering positioning/communications within the sector.

We can also provide strategic studies (position papers, briefs, publications, etc.) regarding healthcare policy for companies interested in examining—with the support of an independent third party and with economic and healthcare-related assessments—those issues key for the development of their business and relations with stakeholders.
All our research activity is carried out making use of a network of sector experts, unique in Italy, working in conjunction with our professionals in all phases of the process to guarantee key input in the technical-scientific assessment of the research and analysis performed.

Advocacy, public affairs and communication

The European House – Ambrosetti facilitates and promotes dialogue between government, the medical-scientific community, healthcare facilities, patients and companies within the sector in order to be able to discuss in an informed, professional and transparent manner, the key issues of healthcare and health.
Our firm provides support to companies in public affairs-related activities with sector experts, stakeholders and qualified representatives of the major public and private healthcare organizations through:

  • Designing opportunities for discussion and debate, including round tables, technical working groups, scientific advisory boards, conferences, workshops, regional road shows and webinars;
  • Preparing issue-related policy briefs to be discussed and shared with other key parties;
  • Organizing high-level technical/institutional events on specific themes around key issues/sectors for healthcare, in order to promote a profitable exchange of ideas and debate among the system’s major players;
  • Supporting external communications activity through the involvement of qualified media agencies and our communications staff.
Changes in healthcare and social security/welfare expenditure from an integrated point of view. The case of cancer in Italy
Meridiano Sanità Sicilia 2020
October 9 – 10, 2020 – Teatro Bellini, Catania
Novartis’ contribution to value creation in the area of neuroscience
Executive Summary
“The cardio-oncological patient journey: comparing experiences
Meridiano Sanità Sicilia – The value of the health ecosystem as a driver of growth, social cohesion and sustainable development for a country
October 18-19, 2019 – Palazzo Reale, Palermo
Family care – New perspectives for the Ageing Society
October 14, 2019 – “Spazio Belvedere Enzo Jannacci”, Palazzo Pirelli (31° piano), Milan
Program and Paper
The pharma manufacturing industry in italy – Current scenario and the outlook to 2030
September 19, 2019 – Sala Zuccari – Palazzo Giustiniani, Rome
Manifest and Infographic
Immunization and Infection Control Management Policies
July 10, 2019 – Zuccari Room – Palazzo Giustiniani, Rome
Event Report
“The value (and the values) of Novartis for our Country
November 13, 2018 – Auditorium Ara Pacis, Rome
Strategic Study
New perspectives in the secondary prevention of cardiovascular disease: focus on hypercholesterolemia
October 24, 2018 – Sala degli Atti Parlamentari – Biblioteca del Senato “Giovanni Spadolini”, Rome

Scale, impact and frontiers in metastatic breast cancer. Initiatives towards increasing value for the patient and the system
October 17, 2018 – Sala Zuccari, Palazzo Giustiniani, Rome
“Health in the cities” International Conference
December 11, 2017 – Parco dei Principi, Rome 
Press Conference “The value of influenza vaccinations: priorities and concrete actions for increasing coverage and improving the health of citizens”
October 13, 2017 – Università Cattolica, Rome
Round Table “Vaccination and Preventive Healthcare The view of the Lombardy Region”
July 21, 2017 – Lombardy Region, Sala Opportunità
Workshop “Overcoming the challenge of dementias. A focus on Alzheimer’s disease”
July 18, 2017 – Grand Hotel De La Minerve, Rome
Round Table – “Public-Private Cooperation in the Lombardy Region. Teva’s contribution to the competitiveness of the regional economy”
April 3, 2017 – Lombardy Region
Forum  Celgene – “The future lies in clinical research. An opportunity for Patients, the National Healthcare System and the Nation”
September 15, 2016 – Palazzo Rospigliosi, Rome
Forum Meridiano Cardio –  “Dimensions of hypercholesterolaemia and priorities of action”
May 24, 2016 – Auditorium – Ministry of Health, Rome
Neurosciences Forum – “A 100 years journey through the mind”
December 3, 2015 – Accademia dei Lincei, Rome
Health and economic growth – The impact of osteoporosis on productivity in the Lombardy Region (It.)
May 27, 2014 – Consiglio Regionale Regione Lombardia
(Quaderno de Il Sole 24 Ore – published in July 2014)
“MERIDIANO SANITA’ DIABETE 2020″ – Final Report (It.)
March 25, 2013  – Palazzo Rospigliosi, Rome

In 2005 The European House – Ambrosetti created a think tank on health-related issues in Italy, thanks to the involvement of experts and key opinion leaders, as well as the support of a number of sector players. The studies and analysis carried out are presented at the Meridiano Sanità Forum held each year in Rome in early November.

Daniela Bianco

Daniela Bianco

Partner, The European House - Ambrosetti

Tel.  +39 02 46753 220